查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995426

微生物鑑定市場：2026-2032年全球市場預測（依產品類型、目標微生物、技術、最終用戶和應用分類）

Microbial Identification Market by Product Type, Organism, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，微生物鑑定市場價值將達到 43.9 億美元，到 2026 年將成長至 47.9 億美元，到 2032 年將達到 89 億美元，年複合成長率為 10.61%。

主要市場統計數據
基準年 2025 43.9億美元
預計年份：2026年 47.9億美元
預測年份 2032 89億美元
複合年成長率 (%) 10.61%

權威概述，將微生物鑑定定位為診斷、調查和公共衛生領域的一項綜合操作和戰略重點。

微生物同定の分野は、臨床診断、食品安全、環境モニタリング、およびライフサイエンス調査が交差する多面的な領域へと成熟しました。機器、消耗品、インフォマティクスにおける近年の進歩により、結果が出るまでの時間が短縮され、感度が向上し、検出可能な微生物の範囲が広がりました。この進化は檢查室のワークフローを一新し、より迅速な臨床判断、より堅牢なサーベイランス、そして擴充性のある調査用途を可能にしました。その結果、組織は業務効率と規制順守を維持するために、従来の慣行と新興技術を両立させなければなりません。

技術、監管和商業性因素的整合正在重塑微生物鑑定領域與實驗室工作流程競爭的價值提案。

微生物同定の分野は、技術の融合的進歩、規制の成熟、そしてエンドユーザーの期待の変化に牽引され、変革的な変化を遂げつつあります。次世代定序および基質輔助雷射脫附游離飛行時間型（MALDI-TOF）プラットフォームは、迅速かつ高解像度の微生物同定を可能にすることで、性能の基準を塗り替えました。同時に、PCRや免疫檢測法は、臨床および産業分野における標的を絞ったハイスループット検査において、依然として不可欠な存在です。これらの補完的な技術は、檢查室がリソースを配分し、ワークフローの優先順位を決定する方法を再定義しています。

2025 年關稅變化和跨境供應趨勢對籌資策略、供應商多角化和業務永續營運決策的影響。

2025年の関税変更と国境を越えた貿易調整がもたらす累積的な影響により、微生物同定製品に関する調達、サプライチェーンのレジリエンス、および総所有コストについて、新たな考慮事項が生じています。関税の変動はベンダーの位置における相対的な魅力に影響を与えており、多くのバイヤーはリスクを軽減するために籌資策略を見直し、地域の供給パートナーを検討するようになっています。その結果、調達チームは、重要な検査業務の継続性を確保するために、檢驗済みの代替サプライヤーを優先し、より長期的なサービス契約を交渉するようになっています。

基於全面細分的洞察，揭示了影響競爭定位和採用趨勢的產品、技術、應用、最終用戶和微生物因素。

製品、技術、用途、エンドユーザー、および微生物の各次元における詳細な分析により、導入が加速している分野と、統合の課題が依然として残っている分野が明らかになります。製品セグメンテーションに基づき、市場は消耗品、機器、およびソフトウェア,サービスに及びます。消耗品にはさらに、アクセサリー、培地、試薬およびキットが含まれ、機器には層析法システム、MALDI-TOF、PCRシステム、シーケン定序システムが含まれます。ソフトウェアおよび関連サービスには、バイオインフォマティクスソフトウェア、同定サービス、保守,サポートが含まれます。この製品アーキテクチャは、消耗品の継続的な需要がラボの経済性を支える一方で、機器およびソフトウェアへの投資が機能の拡張と診断における差別化を推進していることを浮き彫りにしています。

決定每個全球市場技術採用、監管合規和商業化方式的區域趨勢和策略重點。

地域ごとの動向は、南北アメリカ、欧州、中東,アフリカ、アジア太平洋地域において、技術導入の曲線、規制への適合、および戦略的優先事項に影響を与え続けています。南北アメリカでは、市場促進要因として、臨床現場での迅速な導入、保険償還制度との整合性、そして検査の一元化とデータ共用を促進する統合医療システムが重視されています。この地域にサービスを提供するベンダーは、多くの場合、臨床檢驗、拡張可能なサービスネットワーク、および規制当局への申請や保険者との連携を支援するソリューションを優先しています。また、南北アメリカには、調達サイクルや購買力に影響を与える大規模民間および公的な檢查室ネットワークが存在します。

重點闡述推動市場領導地位的關鍵企業級策略和競爭優勢，包括整合解決方案、夥伴關係和創新途徑。

微生物同定分野における競合上のポジショニングは、技術力、檢驗済みのワークフロー、そして商業性的な実行力の融合を反映しています。主要企業は、堅牢な機器、再現性のある消耗品、そして拡張可能なバイオインフォマティクスを組み合わせた統合型ソリューションによって差別化を図っています。これらの企業は、導入時の障壁を低減するため、規制関連資料、臨床および産業用バリデーション、顧客支援プログラムに多額の投資を行っています。その結果、購入者は、ソリューションの整體性、長期的なサービス提供の確約、そして実環境での実績の証拠に基づいてベンダーを評価する傾向が強まっています。

為高階主管提供可操作的建議，以使產品開發、供應鏈彈性和資料能力與客戶工作流程和監管期望保持一致。

業界の領導企業は、製品開発をユーザーのワークフロー、規制上の期待、そして強靭なサプライチェーンの実践と整合させる取り組みを優先すべきです。まず、ラボの顧客にとっての統合負担を軽減し、導入から臨床または産業での實用化までの時間を短縮する、檢驗済みで相互運用可能なソリューションに投資してください。概念驗證データ、包括的な檢驗パッケージ、そして充実したトレーニングプログラムは、導入を加速させ、ベンダーの長期的な信頼性を確立します。さらに、モジュール設計と下位互換性を重視することで、交換コストを低減し、顧客の投資を保護することができます。

採用透明、系統性的研究途徑，結合對實務工作者的訪談、文獻整合和三角測量分析，確保獲得實用且檢驗的見解。

本調査では、一次インタビュー、二次文献、および構造化された分析を統合し、方法論の透明性を維持しつつ、実用的な知見を提供します。主な資訊來源には、檢查室責任者、調達負責人、臨床研究者、規制専門家との対話が含まれ、彼らは導入の障壁、檢驗要件、および購入基準について定性的な見解を提供しました。これらの実務者の知見は、技術固有の性能特性や実環境での導入上の制約の解釈に役立てられました。

簡潔的結論強調，綜合解決方案、證據產生和運作韌性是微生物鑑定領域有意義進展的支柱。

結論として、微生物同定は、技術革新、規制の進化、そして運用上の実用性の交差点に位置しています。現在、檢查室には、分析性能を向上させるだけでなく、ワークフローにシームレスに統合され、データ駆動型の意思決定を支援し、サプライチェーンや貿易の混乱に対するレジリエンスを維持できるソリューションが求められています。機器、消耗品、インフォマティクスが連携して機能するよう設計,檢驗された「システム的觀點」を採用する組織は、より迅速な導入と、より強力な臨床的または運用上のインパクトを実現できるでしょう。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：微生物鑑定市場：依產品類型分類

  • 裝置
    • 微生物鑑定系統
    • PCR和qPCR儀器
    • 定序裝置
    • 質譜儀
    • 流式細胞儀
    • 自動微生物分析儀
  • 試劑和耗材
    • 培養基
      • 乾培養基
      • 製備好的培養基
      • 添加劑和補充劑
    • 識別工具包和麵板
      • 生化鑑定試劑盒
      • 免疫檢測盒
      • 分子檢測試劑盒
    • 卡片和麵板
    • 試劑和緩衝液
    • 實驗室設備和耗材
  • 軟體和服務
    • 數據分析軟體
    • 微生物資料庫和生物資訊學工具
    • 微生物鑑定服務
      • 合約測試服務
      • NGS資料分析服務
      • 客製化檢測開發服務

第9章：依物種分類的微生物鑑定市場

  • 細菌
  • 真菌
  • 寄生蟲
  • 病毒

第10章：微生物鑑定市場：依技術分類

  • 表現型分析方法
    • 手動微生物學
    • 自動化微生物系統
  • 分子生物學方法
    • PCR方法
      • 常規PCR
      • 即時PCR
      • 數位PCR
    • 基於定序的方法
      • 桑格定序
      • 次世代定序
      • 標靶擴增子序列
      • 全基因測序
      • 元基因組定序
    • 等溫擴增
    • 雜合反應和微陣列
  • 質譜分析
    • MALDI-TOF MS
  • 免疫學方法
    • ELISA
    • 橫向流動化驗
    • 聚集試驗
  • 生物感測器和晶片實驗室
  • 流式細胞技術

第11章：微生物鑑定市場：依最終用戶分類

  • 學術研究機構
  • 環境檢測實驗室
  • 食品飲料業
  • 醫院和診斷檢測實驗室
  • 製藥和生物技術公司

第12章：微生物鑑定市場：依應用領域分類

  • 學術研究
  • 臨床診斷
    • 感染疾病
    • 膿毒症的檢測
  • 環境測試
  • 食品和飲料安全
  • 製藥和生物技術

第13章：微生物鑑定市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：微生物鑑定市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：微生物鑑定市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國微生物鑑定市場

第17章：中國微生物鑑定市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accelerate Diagnostics, Inc.
  • Alifax Srl
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biolog, Inc.
  • bioMerieux SA
  • Bruker Corporation
  • CD Genomics.
  • Charles River Laboratories International, Inc.
  • Creative Diagnostics
  • DH Life Sciences, LLC
  • Eurofins Scientific（Ireland）Limited
  • Genefluidics, Inc.
  • Gradian Diagnostics
  • Himedia Laboratories
  • Liofilchem SRL
  • Merck KGaA
  • Metabolon Inc.
  • QIAGEN GmbH
  • Shimadzu Corporation
  • STERIS PLC
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • VWR International, LLC. by Avantor, Inc.
  • Wickham Micro Ltd.
  • Zhuhai DL Biotech. Co.,LTD.
Product Code: MRR-4F4C36263B4B

The Microbial Identification Market was valued at USD 4.39 billion in 2025 and is projected to grow to USD 4.79 billion in 2026, with a CAGR of 10.61%, reaching USD 8.90 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.39 billion
Estimated Year [2026] USD 4.79 billion
Forecast Year [2032] USD 8.90 billion
CAGR (%) 10.61%

An authoritative introduction that frames microbial identification as an integrated operational and strategic priority for diagnostics, research, and public health

The microbial identification landscape has matured into a multidimensional arena that intersects clinical diagnostics, food safety, environmental monitoring, and life sciences research. Recent advancements across instrumentation, consumables, and informatics have accelerated time-to-result, improved sensitivity, and broadened the range of detectable organisms. This evolution has reshaped laboratory workflows, enabling faster clinical decision-making, more robust surveillance, and scalable research applications. As a result, organizations must reconcile legacy practices with emerging technologies to maintain operational efficiency and regulatory compliance.

Meanwhile, changing expectations from clinicians, regulators, and supply-chain managers demand higher throughput, lower per-sample costs, and integrated data management. These pressures have driven closer alignment between instrument vendors, consumables manufacturers, and software providers to deliver end-to-end solutions. Consequently, procurement decisions increasingly weigh lifecycle costs, interoperability, and service support rather than single-point performance metrics. This shift compels leaders to evaluate how new capabilities can be integrated into existing ecosystems while ensuring continuity of care and data integrity.

Taken together, the introduction frames microbial identification not merely as a technical exercise but as a strategic operational domain. Stakeholders must balance scientific performance, regulatory obligations, and commercial realities to extract value from technological innovation while protecting patient safety and public health objectives.

A synthesis of the technological, regulatory, and commercial forces that are reshaping laboratory workflows and competitive value propositions across microbial identification

The landscape for microbial identification is undergoing transformative shifts driven by convergent technological advances, regulatory maturation, and evolving end-user expectations. Next-generation sequencing and matrix-assisted laser desorption ionization time-of-flight platforms have shifted performance baselines by enabling rapid, high-resolution organism characterization. At the same time, PCR and immunoassays remain indispensable for targeted, high-throughput testing in clinical and industrial settings. These complementary technologies are redefining how laboratories allocate resources and prioritize workflows.

Concurrently, software and bioinformatics capabilities have moved from peripheral tools to central components that determine the practical value of raw data. Improved algorithms, cloud-enabled analytics, and laboratory information management integrations allow organizations to scale interpretation and reporting while maintaining traceability. Regulatory landscapes are adapting to accommodate such integrated solutions, prompting vendors to emphasize validated workflows and documented performance. In response, commercial strategies now stress robust service offerings, lifecycle maintenance, and training to lower adoption barriers.

The net effect of these shifts is an emphasis on modular, interoperable ecosystems that support a spectrum of use cases from rapid point-of-care detection to comprehensive epidemiological surveillance. Market participants who align product development with user-centered workflows, regulatory expectations, and demonstrable outcome improvements will capture disproportionate value as laboratories modernize operations and embrace integrated diagnostics.

How evolving tariff regimes and cross-border supply dynamics in 2025 are influencing procurement strategies, supplier diversification, and operational continuity decisions

The cumulative impact of tariff changes and cross-border trade adjustments in 2025 has introduced new considerations for procurement, supply-chain resilience, and total cost of ownership for microbial identification products. Tariff fluctuations have affected the relative attractiveness of vendor locations, prompting many buyers to reassess sourcing strategies and consider regional supply partners to mitigate exposure. As a result, procurement teams have prioritized validated alternative suppliers and negotiated longer-term service agreements to ensure continuity of critical testing operations.

Manufacturers and distributors have responded by diversifying manufacturing footprints and optimizing component sourcing to preserve margins while avoiding price volatility for end customers. This repositioning has accelerated investments in regional facilities and third-party partnerships that can support localized inventory buffers and faster response times. In parallel, strategic inventory management and demand forecasting have become more sophisticated, leveraging historical usage patterns and scenario planning to reduce risk of interruption.

Importantly, these trade environment dynamics have also influenced product development timelines and go-to-market sequencing. Developers now incorporate tariff and logistical sensitivity analyses into launch planning, prioritizing configurations that balance cost-efficiency with regulatory compatibility. For laboratory leaders, the practical implication is an increased focus on contractual flexibility, supplier performance metrics, and contingency planning to sustain diagnostic capacity under variable trade conditions.

Comprehensive segmentation-driven insights that reveal product, technology, application, end-user, and organism levers shaping competitive positioning and adoption

A granular view across product, technology, application, end user, and organism dimensions reveals where adoption is accelerating and where integration challenges persist. Based on product segmentation, the market spans consumables, instruments, and software and services; consumables further include accessories, culture media, and reagents and kits, while instruments encompass chromatography systems, MALDI-TOF, PCR systems, and sequencing systems; software and associated services cover bioinformatics software, identification services, and maintenance and support. This product architecture highlights how recurring consumables demand underpins lab economics, whereas instrument and software investments drive capability expansion and diagnostic differentiation.

From a technology perspective, the domain includes conventional methods, immunoassays, MALDI-TOF, PCR, and sequencing; immunoassays further split into ELISA and lateral flow assays, and sequencing breaks down into next-generation sequencing and Sanger sequencing. These technology pathways represent distinct trade-offs between breadth of detection, speed, cost, and analytical complexity, and laboratories typically deploy a mix of methods to meet diverse testing requirements. Application segmentation shows deployments across academic research, clinical diagnosis, environmental testing, food and beverage safety, and pharmaceutical and biotech; clinical diagnosis specifically distinguishes infectious diseases and sepsis detection. This distribution underscores the cross-sector utility of identification technologies and the varying performance thresholds demanded by each use case.

End users range from academic and research institutes to environmental testing laboratories, food and beverage companies, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology firms. Each user group prioritizes different attributes-throughput, regulatory validation, cost-per-test, or integration capabilities-shaping purchasing criteria and adoption timelines. Finally, organism-focused segmentation spanning bacteria, fungi, parasites, and viruses clarifies that platform versatility and validated detection panels are critical competitive differentiators. Together, these segmentation lenses enable more precise product positioning, targeted validation strategies, and tailored commercial approaches that align with real-world laboratory workflows.

Region-specific dynamics and strategic priorities that determine technology adoption, regulatory alignment, and commercialization approaches across global markets

Regional dynamics continue to influence technology adoption curves, regulatory pathways, and strategic priorities across the Americas, Europe, Middle East and Africa, and Asia-Pacific. In the Americas, market drivers emphasize rapid clinical adoption, reimbursement alignment, and integrated healthcare systems that facilitate centralized testing and data sharing. Vendors serving this region often prioritize clinical validation, scalable service networks, and solutions that support regulatory submissions and payer engagement. The Americas also feature significant private and public laboratory networks that influence procurement cycles and purchasing power.

Europe, the Middle East and Africa present a heterogeneous environment with divergent regulatory regimes and varying infrastructure maturity. Regulatory harmonization efforts in parts of Europe encourage standardized validation approaches, while other markets within the region focus on capacity building and decentralized testing. Vendors that provide flexible deployment models, local support, and compliance documentation find traction across diverse healthcare architectures. Meanwhile, public health programs and regional surveillance priorities drive demand for multiplexed and high-throughput platforms.

Asia-Pacific exhibits robust investment in biotechnology and diagnostic innovation, driven by strong public health priorities, growing clinical research activity, and expanding manufacturing capabilities. Rapid urbanization and increased laboratory capacity accelerate adoption of automated systems and informatics-driven solutions. Across all regions, successful commercial strategies balance global product standards with localized regulatory and operational customization to meet regional laboratory expectations and procurement norms.

Key company-level strategies and competitive differentiators highlighting integrated solutions, partnerships, and innovation pathways driving market leadership

Competitive positioning in microbial identification reflects a blend of technological capability, validated workflows, and commercial execution. Leading organizations differentiate through integrated offerings that combine robust instrumentation, reproducible consumables, and scalable bioinformatics. These companies invest significantly in regulatory dossiers, clinical and industrial validations, and customer enablement programs to reduce adoption friction. As a result, buyers increasingly assess vendors on the comprehensiveness of their solutions, long-term service commitments, and evidence of real-world performance.

Partnerships and channel ecosystems have become critical to extend market reach and provide localized service coverage. Strategic alliances with contract research organizations, regional distributors, and informatics partners allow vendors to accelerate adoption while sharing risk. In parallel, open-platform approaches that support third-party reagents and interoperable data standards can unlock broader adoption, though they require rigorous compatibility testing and support structures. Companies that strike the right balance between proprietary performance and open integration tend to secure sustained customer relationships.

Finally, emerging entrants with focused innovations-such as novel sequencing chemistries, compact mass spectrometry solutions, or AI-driven identification algorithms-have the potential to disrupt incumbents by addressing unmet use cases. Established firms that respond with adaptive product roadmaps, strategic investments, and enhanced service propositions will preserve competitive advantage in a rapidly evolving arena.

Actionable recommendations for executives to align product development, supply resilience, and data capabilities with customer workflows and regulatory expectations

Industry leaders should prioritize actions that align product development with user workflows, regulatory expectations, and resilient supply-chain practices. First, invest in validated, interoperable solutions that reduce integration burdens for laboratory customers and shorten the time from acquisition to clinical or industrial utility. Proof-of-concept data, comprehensive validation packages, and robust training programs will accelerate adoption and establish long-term vendor credibility. Additionally, emphasizing modular designs and backward compatibility can lower replacement costs and protect customer investments.

Second, diversify manufacturing and logistics frameworks to mitigate tariff and geopolitical risks while maintaining predictable service levels. Establishing regional manufacturing or stocking facilities and deepening relationships with trusted distribution partners can preserve continuity and reduce lead times. Third, strengthen bioinformatics and data management capabilities to extract actionable insights from identification workflows; analytic clarity and automated reporting improve clinical utility and demonstrate value to end users. In parallel, cultivate strategic partnerships with clinical networks, food safety agencies, and environmental monitoring bodies to broaden real-world validation opportunities and to align product roadmaps with emergent needs.

Finally, implement customer-centric commercial models that combine bundled solutions, outcome-based contracting where appropriate, and proactive support frameworks. This approach reduces adoption friction, enhances customer retention, and supports rapid scaling of new technologies into routine practice.

A transparent and methodical research approach combining practitioner interviews, literature synthesis, and triangulated analysis to ensure practical and validated insights

This research synthesizes primary interviews, secondary literature, and structured analysis to deliver actionable insights while maintaining methodological transparency. Primary inputs included conversations with laboratory directors, procurement leads, clinical researchers, and regulatory specialists who provided qualitative perspectives on adoption barriers, validation requirements, and purchasing criteria. These practitioner insights informed the interpretation of technology-specific performance characteristics and real-world deployment constraints.

Secondary sources encompassed peer-reviewed literature, regulatory guidance documents, and technical whitepapers that describe assay principles, validation standards, and instrumentation performance characteristics. Where possible, the analysis cross-referenced technical claims with published validation studies and consensus guidance to ensure accuracy. Scenario analyses explored supply-chain sensitivities and tariff impacts, drawing on publicly available trade policy updates and logistics indicators to model potential operational outcomes.

Throughout the methodology, emphasis was placed on triangulation-corroborating claims across multiple independent sources-and on documenting assumptions underlying comparative assessments. The research team also applied a user-centric lens, mapping technological attributes to laboratory workflows and decision criteria to ensure that conclusions translate into practical recommendations for stakeholders.

A concise conclusion emphasizing integrated solutions, evidence generation, and operational resilience as the pillars of meaningful progress in microbial identification

In conclusion, microbial identification sits at the intersection of technological innovation, regulatory evolution, and operational pragmatism. Laboratories now require solutions that not only improve analytic performance but also integrate seamlessly into workflows, support data-driven decision-making, and maintain resilience against supply-chain and trade disruptions. Organizations that adopt a systems perspective-where instruments, consumables, and informatics are designed and validated to work together-will achieve faster adoption and stronger clinical or operational impact.

Moreover, the interplay between regional regulatory environments and procurement dynamics necessitates tailored go-to-market approaches that balance global product standards with localized support models. Companies that invest in strategic partnerships, regional capabilities, and robust evidence generation will reduce adoption friction and expand addressable use cases. For buyers, the imperative is to evaluate vendors on demonstrable clinical or industrial outcomes, lifecycle costs, and the strength of service and validation frameworks rather than on isolated performance claims.

Ultimately, the path to improved microbial identification is iterative: continuous investments in validation, customer enablement, and interoperable ecosystems will deliver tangible benefits in diagnostics, public health surveillance, and industrial quality assurance over the long term.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Microbial Identification Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Microbial Identification Systems
    • 8.1.2. PCR And qPCR Instruments
    • 8.1.3. Sequencing Instruments
    • 8.1.4. Mass Spectrometers
    • 8.1.5. Flow Cytometers
    • 8.1.6. Automated Microbial Analyzers
  • 8.2. Reagents And Consumables
    • 8.2.1. Culture Media
      • 8.2.1.1. Dehydrated Media
      • 8.2.1.2. Prepared Media
      • 8.2.1.3. Supplements And Additives
    • 8.2.2. Identification Kits And Panels
      • 8.2.2.1. Biochemical Identification Kits
      • 8.2.2.2. Immunoassay Kits
      • 8.2.2.3. Molecular Assay Kits
    • 8.2.3. Cards And Panels
    • 8.2.4. Reagents And Buffers
    • 8.2.5. Labware And Disposables
  • 8.3. Software And Services
    • 8.3.1. Data Analysis Software
    • 8.3.2. Microbial Databases And Bioinformatics Tools
    • 8.3.3. Microbial Identification Services
      • 8.3.3.1. Contract Testing Services
      • 8.3.3.2. NGS Data Analysis Services
      • 8.3.3.3. Custom Assay Development Services

9. Microbial Identification Market, by Organism

  • 9.1. Bacteria
  • 9.2. Fungi
  • 9.3. Parasites
  • 9.4. Viruses

10. Microbial Identification Market, by Technology

  • 10.1. Phenotypic Methods
    • 10.1.1. Manual Microbiology
    • 10.1.2. Automated Microbiology Systems
  • 10.2. Molecular Methods
    • 10.2.1. PCR-Based Methods
      • 10.2.1.1. Conventional PCR
      • 10.2.1.2. Real-Time PCR
      • 10.2.1.3. Digital PCR
    • 10.2.2. Sequencing-Based Methods
      • 10.2.2.1. Sanger Sequencing
      • 10.2.2.2. Next-Generation Sequencing
      • 10.2.2.2.1. Targeted Amplicon Sequencing
      • 10.2.2.2.2. Whole-Genome Sequencing
      • 10.2.2.2.3. Metagenomic Sequencing
    • 10.2.3. Isothermal Amplification
    • 10.2.4. Hybridization And Microarrays
  • 10.3. Mass Spectrometry
    • 10.3.1. MALDI-TOF MS
  • 10.4. Immunological Methods
    • 10.4.1. ELISA
    • 10.4.2. Lateral Flow Assays
    • 10.4.3. Agglutination Tests
  • 10.5. Biosensors And Lab-On-A-Chip
  • 10.6. Flow Cytometry

11. Microbial Identification Market, by End User

  • 11.1. Academic And Research Institutes
  • 11.2. Environmental Testing Laboratories
  • 11.3. Food And Beverage Industry
  • 11.4. Hospitals And Diagnostic Laboratories
  • 11.5. Pharmaceutical And Biotechnology Companies

12. Microbial Identification Market, by Application

  • 12.1. Academic Research
  • 12.2. Clinical Diagnosis
    • 12.2.1. Infectious Diseases
    • 12.2.2. Sepsis Detection
  • 12.3. Environmental Testing
  • 12.4. Food And Beverage Safety
  • 12.5. Pharmaceutical And Biotech

13. Microbial Identification Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Microbial Identification Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Microbial Identification Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Microbial Identification Market

17. China Microbial Identification Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accelerate Diagnostics, Inc.
  • 18.6. Alifax S.r.l.
  • 18.7. Beckman Coulter, Inc.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Biolog, Inc.
  • 18.10. bioMerieux SA
  • 18.11. Bruker Corporation
  • 18.12. CD Genomics.
  • 18.13. Charles River Laboratories International, Inc.
  • 18.14. Creative Diagnostics
  • 18.15. DH Life Sciences, LLC
  • 18.16. Eurofins Scientific (Ireland) Limited
  • 18.17. Genefluidics, Inc.
  • 18.18. Gradian Diagnostics
  • 18.19. Himedia Laboratories
  • 18.20. Liofilchem S.R.L.
  • 18.21. Merck KGaA
  • 18.22. Metabolon Inc.
  • 18.23. QIAGEN GmbH
  • 18.24. Shimadzu Corporation
  • 18.25. STERIS PLC
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. Trivitron Healthcare
  • 18.28. VWR International, LLC. by Avantor, Inc.
  • 18.29. Wickham Micro Ltd.
  • 18.30. Zhuhai DL Biotech. Co.,LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MICROBIAL IDENTIFICATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MICROBIAL IDENTIFICATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ORGANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MICROBIAL IDENTIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MICROBIAL IDENTIFICATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR AND QPCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR AND QPCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR AND QPCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIAL ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIAL ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIAL ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DEHYDRATED MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DEHYDRATED MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DEHYDRATED MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PREPARED MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PREPARED MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PREPARED MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SUPPLEMENTS AND ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SUPPLEMENTS AND ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SUPPLEMENTS AND ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOCHEMICAL IDENTIFICATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOCHEMICAL IDENTIFICATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOCHEMICAL IDENTIFICATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CARDS AND PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CARDS AND PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CARDS AND PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LABWARE AND DISPOSABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LABWARE AND DISPOSABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LABWARE AND DISPOSABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL DATABASES AND BIOINFORMATICS TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL DATABASES AND BIOINFORMATICS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL DATABASES AND BIOINFORMATICS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONTRACT TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONTRACT TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONTRACT TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NGS DATA ANALYSIS SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NGS DATA ANALYSIS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NGS DATA ANALYSIS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MANUAL MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MANUAL MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MANUAL MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIOLOGY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIOLOGY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AUTOMATED MICROBIOLOGY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY TARGETED AMPLICON SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY TARGETED AMPLICON SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY TARGETED AMPLICON SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HYBRIDIZATION AND MICROARRAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HYBRIDIZATION AND MICROARRAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HYBRIDIZATION AND MICROARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MALDI-TOF MS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MALDI-TOF MS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY MALDI-TOF MS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AGGLUTINATION TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AGGLUTINATION TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY AGGLUTINATION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOSENSORS AND LAB-ON-A-CHIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOSENSORS AND LAB-ON-A-CHIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY BIOSENSORS AND LAB-ON-A-CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEPSIS DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEPSIS DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY SEPSIS DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PHENOTYPIC METHODS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PCR-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SEQUENCING-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY IMMUNOLOGICAL METHODS, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA MICROBIAL IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY IDENTIFICATION KITS AND PANELS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA MICROBIAL IDENTIFICATION MARKET SIZE, BY MICROBIAL IDENTIFICATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST &